Guangxi launched clinical trials for the male HPV vaccine, experts say vaccination is necessary according to comprehensive reports.

【#Guangxi conducts HPV vaccine male clinical trial##Experts say it is necessary for males to receive HPV vaccine#】Guangxi CDC announced on the 22nd that in September, Guangxi Zhuang Autonomous Region Disease Control and Prevention Center will conduct a phase III clinical trial of HPV vaccine for males, involving a domestically produced nine-valent vaccine. Follow-up will be conducted over 6 years with 500 participants. On August 25th, several clinical experts stated that from the perspective of herd immunity and disease prevention, it is highly necessary for males to receive HPV vaccine. After adaptation verification domestically, male HPV vaccine administration will inevitably be introduced. (From Guangxi CDC, Health Times)